Robert Mikan, MD, MBA, Former Medical Director, Cactus Life Sciences, is in conversation with David Rutledge, President and CEO (Founder), Global Strategic Solutions, LLC. In part 1 of this fireside chat, they discuss how MedTech leaders need to respond to the EU MDR with an adaptive mindset and forward behavior: by breaking down silos in their organizations, updating their SOPs, developing enhanced processes, and thinking like an auditor.
Watch this space for subsequent video snippets of this conversation.
Share this post
About the author
Cactus Life Sciences
Cactus Life Sciences helps pharma, biotech, and medical device organizations worldwide with content strategy, development, and data. We work with medical affairs to disseminate insight-driven information to healthcare professionals, payors, and patients in a range of formats.